Upgrades:
Automatic Data Processing (NYSE:ADP) was upgraded by
investment analysts at Morgan Stanley from an “underweight” rating to an
“equal” rating in a research report issued to clients and investors on Tuesday.
A number of other brokerages have also issued reports on ADP. BidaskClub raised
shares of Automatic Data Processing from a “hold” rating to a “buy” rating in a
report on Thursday, September 28th. BMO Capital Markets cut their price
objective on shares of Automatic Data Processing from $122.00 to $114.00 and
set an “outperform” rating for the company in a report on Friday, November 3rd.
Bank of America Corporation increased their price objective on shares of
Automatic Data Processing from $111.00 to $114.00 and gave the company a
“neutral” rating in a report on Friday, October 13th. Barclays PLC reaffirmed
an “equal weight” rating and set a $105.00 price objective on shares of
Automatic Data Processing in a report on Tuesday, August 15th. Read more …
Air Products and Chemicals, Inc. (NYSE:APD) was upgraded by
investment analysts at HSBC Holdings plc from a “hold” rating to a “buy” rating
in a research note issued on Monday, The Fly reports. A number of other
brokerages also recently commented on APD. Deutsche Bank AG boosted their
target price on shares of Air Products and Chemicals from $160.00 to $168.00
and gave the stock a “hold” rating in a report on Wednesday, August 2nd.
Susquehanna Bancshares Inc boosted their target price on shares of Air Products
and Chemicals and gave the stock a “positive” rating in a report on Tuesday,
November 7th. Jefferies Group LLC reiterated a “hold” rating and issued a
$155.00 target price on shares of Air Products and Chemicals in a report on
Thursday, September 28th. SunTrust Banks, Inc. reiterated a “buy” rating and
issued a $175.00 target price on shares of Air Products and Chemicals in a
report on Friday, October 27th. Read more …
Coca-Cola Company (The) (NYSE:KO) was upgraded by investment
analysts at Wells Fargo & Company from a “market perform” rating to an
“outperform” rating in a note issued to investors on Tuesday, The Fly reports. Several
other equities research analysts have also recently weighed in on the company.
Vetr upgraded Coca-Cola Company (The) from a “sell” rating to a “strong-buy”
rating in a research note on Tuesday, September 12th. Royal Bank Of Canada set
a $49.00 target price on Coca-Cola Company (The) and gave the company a “buy”
rating in a report on Sunday. UBS AG boosted their target price on Coca-Cola
Company (The) from $49.00 to $51.00 and gave the company a “buy” rating in a
report on Thursday, July 27th. Read more …
Sanofi (NYSE:SNY) was upgraded by equities research analysts
at Barclays PLC from an “underweight” rating to an “equal weight” rating in a
research report issued on Wednesday. A number of other research firms also
recently weighed in on SNY. Zacks Investment Research downgraded Sanofi from a
“hold” rating to a “strong sell” rating in a research report on Friday, October
6th. raised Sanofi from a “reduce” rating to a “hold” rating in a research
report on Wednesday, August 30th. Argus reissued a “buy” rating and set a
$55.00 target price on shares of Sanofi in a research report on Friday,
September 1st. J P Morgan Chase & Co reissued a “neutral” rating on shares
of Sanofi in a research report on Friday, September 15th. Finally, BidaskClub
raised Sanofi from a “sell” rating to a “hold” rating in a research report on Saturday,
August 5th. Read more ...
Occidental Petroleum Corporation (NYSE:OXY) was upgraded by
stock analysts at The Goldman Sachs Group, Inc. from a “neutral” rating to a
“buy” rating in a report released on Friday. A number of other research
analysts have also weighed in on OXY. Morgan Stanley raised their price target
on shares of Occidental Petroleum Corporation from $62.00 to $66.00 and gave
the company an “equal weight” rating in a research note on Wednesday, October
18th. Jefferies Group LLC set a $58.00 price target on shares of Occidental
Petroleum Corporation and gave the company a “hold” rating in a research report
on Tuesday, August 29th. Read more …
Downgrades:
Argus lowered shares of Gilead Sciences, Inc. (NASDAQ:GILD)
from a buy rating to a hold rating in a research report released on Monday
morning. Argus currently has $73.77 target price on the biopharmaceutical
company’s stock, up from their previous target price of $73.25. Several other
equities research analysts have also recently issued reports on the stock.
Mizuho lifted their price objective on shares of Gilead Sciences from $77.00 to
$83.00 and gave the company a buy rating in a research report on Wednesday,
November 8th. Maxim Group reiterated a hold rating on shares of Gilead Sciences
in a research report on Friday, October 27th. BMO Capital Markets reduced their
price objective on shares of Gilead Sciences from $89.00 to $83.00 and set an
outperform rating on the stock in a research report on Friday, October 27th. J
P Morgan Chase & Co set a $85.00 price objective on shares of Gilead
Sciences and gave the company a buy rating in a research report on Wednesday,
October 25th. Read more …
J P Morgan Chase & Co downgraded shares of Rio Tinto PLC
(NYSE:RIO) from an overweight rating to a neutral rating in a research report
report published on Monday morning, MarketBeat Ratings reports. Other equities
research analysts have also issued research reports about the stock. Societe
Generale upgraded shares of Rio Tinto PLC from a hold rating to a buy rating in
a research note on Wednesday, November 8th. Citigroup Inc. downgraded shares of
Rio Tinto PLC from a buy rating to a neutral rating in a research note on
Tuesday, October 17th. Cowen and Company set a $47.00 price target on shares of
Rio Tinto PLC and gave the company a hold rating in a report on Monday, October
16th. Clarkson Capital lowered shares of Rio Tinto PLC from a buy rating to a
neutral rating in a research report on Monday, October 16th. Read more …
Schlumberger N.V. (NYSE:SLB) was downgraded by investment
analysts at Goldman Sachs Group, Inc. (The) from a “conviction-buy” rating to a
“buy” rating in a report released on Monday. They currently have a $75.00 price
target on the oil and gas company’s stock. Goldman Sachs Group, Inc. (The)’s
price target indicates a potential upside of 19.46% from the stock’s current
price. SLB has been the topic of several other reports. Zacks Investment
Research lowered Schlumberger N.V. from a “hold” rating to a “sell” rating in a
report on Wednesday, November 1st. FBR & Co reissued a “buy” rating on
shares of Schlumberger N.V. in a report on Friday, October 20th. Piper Jaffray
Companies set a $74.00 target price on Schlumberger N.V. and gave the stock a
“buy” rating in a report on Saturday, October 21st. Sanford C. Bernstein
reissued an “outperform” rating and set a $80.00 target price on shares of
Schlumberger N.V. in a report on Wednesday, September 6th. Read more …
J P Morgan Chase & Co downgraded shares of Teva
Pharmaceutical Industries Limited (NYSE:TEVA) from a neutral rating to an
underweight rating in a report published on Monday morning. The firm currently
has $11.00 price objective on the stock, down from their previous price
objective of $11.48. A number of other research firms have also recently
weighed in on TEVA. Jefferies Group LLC restated a hold rating on shares of
Teva Pharmaceutical Industries Limited in a report on Tuesday, July 25th. Vetr
upgraded Teva Pharmaceutical Industries Limited from a hold rating to a buy
rating and set a $34.17 price target on the stock in a report on Monday, July
24th. Zacks Investment Research upgraded Teva Pharmaceutical Industries Limited
from a sell rating to a hold rating in a report on Monday, July 17th. Royal
Bank Of Canada restated an outperform rating and issued a $37.00 price target
(down previously from $38.00) on shares of Teva Pharmaceutical Industries
Limited in a report on Monday, July 17th. Read more …
Phillips 66 (NYSE:PSX) was downgraded by stock analysts at
Barclays PLC from an “equal weight” rating to an “underweight” rating in a note
issued to investors on Tuesday. They presently have a $100.00 price target on
the oil and gas company’s stock, up from their prior price target of $95.00.
Barclays PLC’s price target indicates a potential upside of 7.49% from the
company’s previous close. A number of other analysts have also recently weighed
in on PSX. Scotiabank set a $86.00 price target on Phillips 66 and gave the
company a “hold” rating in a research report on Tuesday, August 1st. BidaskClub
cut Phillips 66 from a “hold” rating to a “sell” rating in a research report on
Friday, August 18th. Jefferies Group LLC reiterated a “hold” rating and issued
a $78.00 price target on shares of Phillips 66 in a research report on Tuesday,
September 5th. Piper Jaffray Companies reiterated a “buy” rating and issued a
$98.00 price target on shares of Phillips 66 in a research report on Tuesday,
September 26th. Read more ...
Cardinal Health, Inc. (NYSE:CAH) was downgraded by stock
analysts at Argus from a “buy” rating to a “hold” rating in a note issued to
investors on Wednesday. Several other equities analysts have also recently
commented on CAH. Jefferies Group LLC lowered their price target on shares of
Cardinal Health from $77.00 to $67.00 and set a “hold” rating on the stock in a
report on Tuesday, November 7th. Zacks Investment Research upgraded shares of
Cardinal Health from a “sell” rating to a “hold” rating in a report on
Wednesday, November 8th. BidaskClub cut shares of Cardinal Health from a “hold”
rating to a “sell” rating in a report on Friday, August 4th. Credit Suisse
Group decreased their price objective on shares of Cardinal Health from $87.00
to $81.00 and set an “outperform” rating for the company in a report on
Thursday, August 3rd. Read more ...
Williams-Sonoma, Inc. (NYSE:WSM) was downgraded by research
analysts at J P Morgan Chase & Co from an “overweight” rating to an
“underweight” rating in a research note issued to investors on Friday. A number
of other research firms have also issued reports on WSM. Robert W. Baird set a
$48.00 price target on Williams-Sonoma and gave the company a “hold” rating in
a research report on Tuesday, October 31st. Zacks Investment Research lowered
Williams-Sonoma from a “buy” rating to a “sell” rating in a research report on
Wednesday. TheStreet raised Williams-Sonoma from a “c+” rating to a “b-” rating
in a research report on Monday, October 9th. Credit Suisse Group lowered
Williams-Sonoma from a “neutral” rating to an “underperform” rating and set a
$44.00 target price on the stock. in a research report on Thursday, October
12th. Read more …
Comments
Post a Comment